| Osteoporosis |
1 |
1 |
| Bone Density |
0 |
0.8 |
| Bone |
0 |
0.98 |
| Exercise |
0 |
0.99 |
| Metabolic Bone Disorder |
0 |
0.47 |
| Osteoarthritis |
0 |
0.46 |
| Spine |
0 |
0.44 |
| Fractures |
0 |
0.42 |
| Vitamin |
0 |
0.23 |
| Calcium |
0 |
0.97 |
| Pain Management |
0 |
0.15 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.11 |
| HIV Infection |
0 |
0.11 |
| Angina Pectoris |
0 |
0.1 |
| Minerals |
0 |
0.1 |
| Menopause |
0 |
0.96 |
| Patient Safety |
0 |
0.09 |
| Bisphosphonate |
0 |
0.95 |
| Muscle |
0 |
0.08 |
| Osteopenia |
0 |
0.08 |
| Femoral Neck |
0 |
0.07 |
| Lumbar Spine |
0 |
0.07 |
| Clinical Guidelines |
0 |
0.06 |
| Femoral Neck Fracture |
0 |
0.06 |
| Constipation |
0 |
0.05 |
| Wound Management |
0 |
0.05 |
| Adverse Effects |
0 |
0.04 |
| Arthralgia |
0 |
0.04 |
| Cervical Region |
0 |
0.04 |
| Chest Pain |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Femoral |
0 |
0.04 |
| Nebraska |
0 |
0.04 |
| Pain |
0 |
0.04 |
| Adherence |
0 |
0.03 |
| Aromatase Inhibitors |
0 |
0.03 |
| Selective Estrogen Receptor Modulators |
0 |
0.03 |
| Biomarker |
0 |
0.02 |
| Blood |
0 |
0.02 |
| Diet |
0 |
0.02 |
| Dizziness |
0 |
0.02 |
| Estrogen |
0 |
0.02 |
| Hand |
0 |
0.02 |
| Hip Fracture |
0 |
0.02 |
| Injury |
0 |
0.02 |
| Metabolism |
0 |
0.02 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.02 |
| Nursing Research |
0 |
0.02 |
| Scan |
0 |
0.02 |
| Stress |
0 |
0.02 |
| Thorax |
0 |
0.02 |